✦ LIBER ✦

Triple negative breast cancers – Can we safely omit chemotherapy in selected node-negative patients?

✍ Scribed by Knight, Alexandra; Subramanian, Ash; Allan, Simon; Shah, Elizabeth

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ADJUVANT CHEMOTHERAPY IN THE NODE-NEGATI

✍ Styblo, Toncred Marya; Wood, William C. 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 880 KB

The evolution in management of patients

✍ Wolfe, Emily; Corsetti, Ralph; Bolton, John S.; Stolier, Alan J.; Fuhrman, Georg 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Omitting axillary lymph node dissection

✍ Hans Torrenga; Hans Fabry; Joost R.M. van der Sijp; Paul J. van Diest; Rik Pijpe 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Selection Criteria for Epirubicin-Based

✍ Fritz Jänicke 📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 245 KB

Prognostic value of Ki-67 labeling index

✍ Elisabetta Munzone, E. Botteri, A. Sciandivasci, G. Curigliano, F. Nolè, M. Mast 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 246 KB

Can sentinel lymph node biopsy avoid axi

✍ S. Zurrida; V. Galimberti; P. Veronesi; V. Sacchini; G. Mazzarol; B. Bonanni; G. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 151 KB